Patent or proprietary medicines require a mark showing special trade connection; a common house mark alone is not enough.

Tariff item 14-E of the Central Excises and Salt Act, 1944 applied only to patent or proprietary medicines, meaning preparations bearing a non-pharmacopoeial name or a brand mark showing a trade connection with the particular medicine. The Madras HC held that a manufacturer's name or a common house mark used across all products did not, by itself, establish a proprietary character in the three pharmaceutical preparations. Because the mark relied on was not a distinct brand assigned only to those medicines, the preparations did not fall within tariff item 14-E and were not excisable as patent or proprietary medicines; the excise demand was quashed.

---

---

Issues: Whether the three pharmaceutical preparations manufactured by the assessee were patent or proprietary medicines falling under tariff item 14-E of the First Schedule to the Central Excises and Salt Act, 1944.

Analysis: Tariff item 14-E applied to patent and proprietary medicines. The Explanation covered medicines bearing a name not specified in a pharmacopoeia or a brand name or other mark used to indicate a connection in trade between the medicine and the person entitled to use the mark. The decisive question was whether the mark used on the labels showed a proprietary interest in the medicines. The mark relied on by the department was a common symbol used by the assessee on all its products and letterheads, and not a distinctive brand assigned only to the three preparations. A manufacturer's name appearing on a medicinal preparation, by itself, did not establish that the medicine was a special proprietary product.

Conclusion: The three preparations did not fall under tariff item 14-E and were not excisable as patent or proprietary medicines; the demand for excise duty was therefore unsustainable and was quashed in favour of the assessee.

Ratio Decidendi: A medicinal preparation is not a patent or proprietary medicine merely because it bears the manufacturer's name or a common house mark; to attract tariff item 14-E, the mark must indicate a special proprietary connection with the particular medicine.

---